The mechanisms of major histocompatibility complex (MHC) class I downregulation during Epstein-Barr virus (EBV) replication are not well characterized. Here we show that in several cell lines infected with a recombinant EBV strain encoding green fluorescent protein (GFP), the virus lytic cycle coincides with GFP expression, which thus can be used as a marker of virus replication. EBV replication resulted in downregulation of MHC class II and all classical MHC class I alleles independently of viral DNA synthesis or late gene expression. Although assembled MHC class I complexes, the total pool of heavy chains, and ␤ 2 -microglobulin (␤ 2 m) were significantly downregulated, free class I heavy chains were stabilized at the surface of cells replicating EBV. Calnexin expression was increased in GFP ؉ cells, and calnexin and calreticulin accumulated at the cell surface that could contribute to the stabilization of class I heavy chains. Decreased expression levels of another chaperone, ERp57, and TAP2, a transporter associated with antigen processing and presentation, correlated with delayed kinetics of MHC class I maturation. Levels of both class I heavy chain and ␤ 2 m mRNA were reduced, and metabolic labeling experiments demonstrated a very low rate of class I heavy chain synthesis in lytically infected cells. MHC class I and MHC class II downregulation was mimicked by pharmacological inhibition of protein synthesis in latently infected cells. Our data suggest that although several mechanisms may contribute to MHC class I downregulation in the course of EBV replication, inhibition of MHC class I synthesis plays the primary role in the process.
Epstein-Barr virus (EBV) is a human gammaherpesvirus, which causes infectious mononucleosis and is associated with a number of malignancies arising from B cells, epithelial cells, and other cell lineages. EBV establishes latent infection predominantly, if not exclusively, in B lymphocytes, but virus replication can occur in both B lymphocytes and epithelial cells of the oropharynx. In the course of virus replication, approximately 70 lytic cycle proteins are expressed in EBV-infected cells in three temporal stages: immediate early (IE), early, and late. Entry into the lytic cycle is triggered by expression of either of the two IE genes BZLF1 and BRLF1. Both the BZLF1 and BRLF1 proteins function as transcriptional activators and initiate the ordered cascade of viral lytic gene expression culminating in the release of infectious virus (reviewed in reference 18).
The majority of EBV carriers mount strong cytotoxic Tlymphocyte (CTL) responses specific to EBV lytic cycle antigens (5, 6, 15) . EBV-specific CTLs appear to play the most important role in the immunological control of EBV replication and EBV-induced malignant transformation. CTLs recognize their target cells through major histocompatibility complex (MHC) class I molecules loaded with antigen-derived peptides. Peptide ligands are generated in the cytosol by the proteolytic action of the proteasome and trimming peptidases and then translocated into the endoplasmic reticulum (ER) by heterodimeric transporters associated with antigen presentation 1 and 2 (TAP1 and TAP2). In the ER, MHC class I heavy chains interact with the chaperone calnexin, followed by interaction with the chaperones calreticulin, ERp57, and ␤ 2 -microglobulin (␤ 2 m) and a preformed complex of TAPs and tapasin. This peptide loading complex is essential for efficient assembly of MHC class I complexes and their egress from the ER through the Golgi to the cell surface (reviewed in reference 8).
To escape from CD8 ϩ T-cell recognition and destruction, viruses have developed strategies to inhibit the expression of MHC class I. These mechanisms include transcriptional downregulation of the heavy chain expression, interference with antigen processing by the proteasome, blocking of peptide transport into the ER, dislocation of MHC class I heavy chains from the ER to the cytosol for subsequent degradation, retention of MHC class I in the ER, and targeted degradation of class I from post-ER compartments. Several of these strategies for herpes simplex virus, varicella-zoster virus, Kaposi's sarcoma-associated herpesvirus, and most notably cytomegalovirus (CMV) have been dissected in detail previously (reviewed in references 19 and 36) .
EBV replication also results in downregulation of MHC class I molecules at the surface of infected cells. However, the mechanisms of this process are not well understood. Previous studies have shown that in lymphoblastoid cell lines, the EBV lytic cycle and MHC class I downregulation are paralleled by downregulation of MHC class II, CD40, and CD54 while CD19, CD80, and CD86 are not affected, pointing to a possible specificity of the process (16) . Reduction of MHC class I expression was found to be an early lytic cycle event that was not dependent on viral DNA replication. The immediate-early BZLF1 protein was implicated in MHC class I downregulation in lymphoblastoid cell lines through inhibition of latent membrane protein 1 (LMP1), which upregulates MHC class I expression in cells latently infected by EBV and is also expressed throughout the lytic cycle. A more efficient system has been developed recently to study EBV replication based on transfection of EBV-positive Akata cells with a reporter which is expressed during the lytic cycle, allowing identification and isolation of cells supporting virus replication from those in latency (29) . Experiments performed with this model revealed that the capacity of the TAP1/TAP2 heterodimer to translocate peptides into the ER is inhibited by up to 70% during EBV replication, and because the expression of MHC class I heavy chains was found to be unaltered, it was suggested that this mechanism plays the primary role in downregulation of MHC class I molecules in the course of EBV replication (29) .
In this study, we made use of a similar model based on a recombinant Akata virus carrying a cassette expressing green fluorescent protein (GFP) and the neomycin resistance gene inserted into the open reading frame of the nonessential thymidine kinase gene (34) . We show that in these cells, the GFP gene is expressed during the lytic cycle with kinetics similar to those of the early EBV lytic genes. Thus, cells expressing GFP can be identified, separated, and used for immunological or biochemical analysis of changes caused by virus replication in EBV-infected cells. Our results show that even though multiple mechanisms might operate during EBV lytic replication, inhibition of MHC class I heavy chains and ␤ 2 m synthesis is one of the key mechanisms of EBV-induced MHC class I downregulation.
MATERIALS AND METHODS
Cell lines and induction of EBV replication. The Bx1g variants of the Burkitt's lymphoma cell line Akata (Akata Bx1g), the gastric carcinoma cell line AGS (AGS Bx1g), and the colorectal epithelial carcinoma cell line HCT116 (HCT116 Bx1g) were obtained by the infection of EBV-negative Akata, AGS, and HCT116 cells with a recombinant virus originated from the EBV strain derived from the wild-type Akata cells. The recombinant virus was generated by introducing a cassette containing the neomycin resistance gene under the control of a thymidine kinase promoter and a modified GFP gene under the control of the immediate-early cytomegalovirus promoter into the open reading frame of the nonessential thymidine kinase gene (refer to reference 24 for more details on the generation of the virus). The Bx1g cell variants were grown in medium supplemented with 500 g/ml of Geneticin sulfate (G418; Sigma Aldrich, Saint Louis, MO). In Akata Bx1g cells, the EBV lytic cycle was induced by culturing in the presence of 50 g/ml goat F(abЈ) 2 fragments specific to human immunoglobulin G (IgG; MP Biomedicals, Aurora, OH) for the indicated periods of time. The lytic cycle in AGS Bx1g and HCT116 Bx1g cells was induced by culturing for 24 h with 30 ng/ml of 12-O-tetradecanoylphorbol-13-acetate (TPA; Sigma Aldrich) and 0.5 mM sodium butyrate (Calbiochem, San Diego, CA). The chemicals were then removed, and the culturing was continued for the indicated periods of time. All cells were grown in RPMI 1640 supplemented with L-glutamine and 10% fetal calf serum.
To inhibit viral DNA replication and late lytic cycle gene expression or to block protein synthesis, cells were cultured in the presence of 0.2 mM acyclovir (Alpharma, Oslo, Norway) or 50 g/ml cycloheximide (Sigma Aldrich), respectively. Antibodies. BZ.1 (Dako, Glostrup, Denmark) is a monoclonal antibody (MAb) specific to the immediate-early BZLF1 protein of EBV. 85K and 2L10 are MAbs specific to the p85 early antigen of EBV and to the late envelope glycoprotein gp350/220, respectively. W6/32 (HB95; ATCC) is a pan-MHC class I-specific MAb which recognizes heavy chains associated with ␤ 2 m. r␣HC (rabbit anti-heavy chain) is a rabbit antiserum that recognizes free heavy chains of MHC class I molecules encoded by the human leukocyte antigen A (HLA-A), B, or C locus (32) and HC10 is a MAb that binds to a linear epitope exposed on free heavy chains of the HLA-B and -C loci (32) . Both Abs were a kind gift of Hidde Ploegh (Harvard Medical School, Boston, MA). The anti-HLA-A (clone 108-2C5) and -HLA-B (clone Joan-1) MAbs were both from Lab Vision (Fremont, CA). The L31 Ab recognizes a linear ␣1 domain epitope exposed on free heavy chains of HLA-C (a kind gift of Louise Berg, Karolinska Institute, Stockholm, Sweden). Abs specific to ERp57 or calreticulin (both from StressGen, Victoria, Canada), calnexin (Abcam, Cambridge, United Kingdom), or tapasin (BD Biosciences) were used for both flow cytometry and immunoblotting. Abs specific to ␤ 2 m, clone TÜ 99 (BD Biosciences, San Jose, CA), and TAP1 or TAP2 (BD Biosciences), as well as fluorescein isothiocyanate-conjugated Ab against MHC class I, MHC class II, CD19, and CD86 (all from BD Biosciences) were used for flow cytometry. Rabbit antiserum specific to ␤ 2 m (Dako), Abs against the proteasomal subunits LMP2, LMP7, MECL1 (monoclonal antibodies), and ␣3 (rabbit polyclonal) (Affinity Research, Plymouth Meeting, PA) as well as GFPspecific Ab (Roche, Indianapolis, IN) or actin-specific Ab (Sigma Aldrich) were used only for immunoblotting. The tripeptidyl peptidase II (TPPII)-specific MAb was from Immunesystem (Uppsala, Sweden). The TAP1-and TAP2-specific Abs used in immunoblotting were a kind gift from John Trowsdale (Cambridge Institute for Medical Research, Cambridge, United Kingdom). All antibody preparations used as isotype controls for flow cytometry were purchased from either Dako or BD Biosciences. The goat anti-mouse allophycocyanin (APC)-conjugated antibody for indirect immunostaining was purchased from BD Biosciences. The relevant secondary antibodies for immunoblotting were purchased form Amersham Biosciences (Uppsala, Sweden).
Flow cytometry. At the indicated time points after induction, Akata Bx1g, AGS Bx1g, or HCT116 Bx1g cells were washed twice in phosphate-buffered saline (PBS), fixed for 25 min in Cytofix/Cytoperm (BD Biosciences), washed three times in Perm/Wash solution (BD Biosciences), and blocked for 30 min on ice with serum from an EBV-negative individual (5% in PBS). Samples were then incubated for 30 min on ice with primary unconjugated Abs, washed, and incubated with goat anti-mouse APC-conjugated Ab for an additional 30 min on ice. All acquisitions were performed on a FACScalibur flow cytometer and analyzed using CellQuest (BD Biosciences). Double stainings were performed by labeling cells first with unconjugated BZLF1-specific Ab, whose binding was revealed by staining with a relevant anti-mouse conjugate, as described above, followed by staining with MHC class I-, class II-, CD19-, or CD86-specific directly conjugated Ab. Staining for HLA-C with L31 Ab, which recognizes free HLA-C heavy chains, was performed after the cells were treated for 2 min with a low-pH buffer (0.131 M citric acid, 0.066 M Na 2 HPO 4 , pH 3.3) to elute the peptides and dissociate the heavy chain from ␤ 2 m.
Analysis of protein expression by immunoblotting. Akata Bx1g cells were induced with IgG-specific Abs for either 24 or 48 h and then sorted using a MoFlo sorter (Dako Cytomation) into GFP ϩ and GFP Ϫ cells. 7AAD (BD Biosciences) was used to exclude dead cells during sorting. Cells were counted and pelleted, and the same numbers of GFP-positive cells and GFP-negative cells were lysed in reducing electrophoresis sample buffer (1 ϫ 10 6 cells/100 l). Electrophoresis was carried out on 10% polyacrylamide gels or 8 to 16% polyduramide gradient gels (Cambrex, East Rutherford, NJ) and proteins were transferred onto nitrocellulose membranes (Bio-Rad, Hercules, CA). Membranes were blocked in PBS containing 5% skimmed milk and probed with different primary Abs followed by secondary antibodies conjugated to horseradish peroxidase. The signal was detected using Super Signal chemiluminescence detection solution (Pierce, Rockford, IL), and images were acquired on a LAS-3000 luminescent image analyzer (Fujifilm Medical Systems, Stamford, CT).
Pulse-chase experiments, immunoprecipitation and MHC class I maturation. Lytic cycle was induced in Akata Bx1g cells for 24 or 48 h, which were then sorted into GFP ϩ (lytic) and GFP Ϫ (latent), as described above. For metabolic labeling, 2 ϫ 10 6 cells/sample were incubated in methionine-and cysteine-free DMEM (Invitrogen, Carlsbad, CA) at 37°C for 1 h, spun down, and resuspended in fresh prewarmed methionine-and cysteine-free Dulbecco's modified Eagle ' To assess the role of protein degradation, cells were incubated in methionineand cysteine-free DMEM at 37°C for 1 h in the presence of the proteasomal inhibitor lactacystine (10 M) and the lysosomal inhibitor chloroquine (4 M) (Sigma). Cells were labeled for 20 min with 400 Ci Redivue Pro-mix, washed, and then pelleted.
For the assessment of MHC class I maturation, cells were pulsed for 30 min, labeling was terminated as described above, cells were washed once and reincubated in prewarmed DMEM containing excess unlabeled L-methionine and Lcysteine and 10% fetal calf serum. Samples were collected immediately after the pulse (time zero) and at 1 h and 2 h of chase.
Samples were lysed in lysis buffer (10 mM Tris, pH 7.4, 1% Triton X-100, 1 mM EDTA, 150 mM NaCl, 2 mM phenylmethylsulfonyl fluoride) on ice. After 30 min, nuclei were removed by centrifugation (relative centrifugal force, 3,000; 10 min). MHC class I molecules were immunoprecipitated with either W6/32 or r␣HC Abs after preclearing with mouse or rabbit serum, respectively.
For endo-␤-N-acetylglucosaminidase H (endoH) digestion, immune complexes bound to protein A Sepharose beads were eluted by incubation at 95°C for 5 min in elution buffer (0.1 M sodium acetate, 3 mM EDTA, 0.25% sodium dodecyl sulfate [SDS], pH 6.0). One half of each sample was digested overnight at 37°C with 2 mU endoH (Roche, Mannheim, Germany), and the other half was mock digested. Samples were mixed with reducing electrophoresis loading buffer and analyzed by SDS-polyacrylamide gel electrophoresis (PAGE) on a 10% polyacrylamide gel. Gels were fixed (40% methanol, 10% acetic acid, 5% glycerol), vacuum dried, and incubated in a Hypercassette (Amersham), and the signal was revealed in a Storm 860 PhosphorImager (Molecular Dynamics, GE Healthcare).
Real-time RT-PCR (RNA preparation and reverse transcription). After induction of the lytic cycle, Akata Bx1g cells were sorted into GFP Ϫ and GFP Real-time PCR. A total of 2.5 l of cDNA was used in a 25-l reaction mixture containing 1ϫ SYBR green (Applied Biosystems, Foster City, CA) and 300 nM of each primer. Primers and primer sequences were as follows: HLA class I-F, 5Ј-ACC TGG AGA ACG GGA AGG A-3Ј; HLA class I-R, 5Ј-TGT GAT CTC CGC AGG GTA GAA-3Ј; ␤ 2 m-F, 5Ј-GAT GAG TAT GCC TGC CGT GTG-3Ј; ␤ 2 m-R, 5Ј-CAA TCC AAA TGC GGC ATC T-3Ј; G6PD-F, 5Ј-TGC CCC CGA CCG TCT AC-3Ј; G6PD-R, 5Ј-ATG CGG TTC CAG CCT ATC TG-3Ј; ABL-F, 5Ј-CGA AGG GAG GGT GTA CCA TTA C-3Ј; ABL-R, 5Ј-CGT TGA ATG ATG ATG AAC CAA CTC-3Ј. The PCR was performed and analyzed on the ABI 7000 sequence detection system with the following PCR conditions: 50°C for 2 min, 95°C for 10 min, followed by 40 PCR amplification cycles with 95°C for 15 s and 60°C for 1 min. Relative quantification of gene expression was calculated according to the Delta-Delta C T method. The formula used was 2
͑⌬CT͒
, where ⌬C T equals the cycle threshold (C T ) of a given gene in GFP ϩ cells minus the C T of the same gene in GFP Ϫ cells.
RESULTS
An alternative model for EBV lytic replication. Analysis of EBV lytic replication has been hampered by the lack of suitable permissive systems of virus infection. Recently, Ressing et al. described a new experimental model of EBV replication based on transfection of Burkitt's lymphoma Akata cells with a plasmid encoding the rat CD2 extracellular and transmembrane domains, with the cytosolic domain replaced with GFP (29) . Expression of the fusion protein in this construct is driven by the BMRF1 early gene promoter. Upon induction of the lytic cycle by cross-linking of surface immunoglobulins, transfected cells supporting virus replication could be either studied based on their GFP expression or isolated with anti-rat CD2 beads (29) .
We made use of an alternative system in which a cassette encoding the GFP gene under control of the CMV immediateearly promoter was inserted into the open reading frame of the nonessential thymidine kinase gene of the wild-type Akata virus (34) . This recombinant virus was used to infect an EBVnegative variant of the Akata cell line, the gastric carcinoma cell line AGS, and the colorectal epithelial carcinoma cell line HCT116, generating EBV-positive cell lines referred to as Akata Bx1g, AGS Bx1g, and HCT116 Bx1g, respectively.
Cultures of cells infected with the recombinant virus typically contained a small population of cells in lytic replication (Fig. 1A , upper panels; data not shown for HCT116 Bx1g cells). In Akata Bx1g cells, the expression of the immediateearly gene BZLF1 quite strictly coincided with expression of GFP, whereas both GFP single-positive and GFP/BZLF1 double-positive populations could be clearly distinguished in AGS Bx1g cells and HCT116 Bx1g cells before and after induction of the lytic cycle. This probably reflects the higher steady-state activity of the CMV promoter in epithelial cells. Upon induction of the lytic cycle by surface IgG cross-linking or TPA and sodium butyrate, the proportions of Akata Bx1g and AGS Bx1g cells replicating EBV increased from approximately 2% to 40% and from 3% to 10%, respectively.
In accordance with previous reports, cells supporting lytic replication expressed decreased surface levels of MHC class I (Fig. 1A , lower panels, and B) and MHC class II (Fig. 1C) . Induction of the virus lytic cycle increased the number of cells with low levels of surface MHC class I in Akata Bx1g, AGS Bx1g ( Fig. 1A and B, lower panels), and HCT116 Bx1g (data not shown) cells, although the kinetics of this process was slower in the epithelial cells, with visible increase of the GFP/ BZLF1 double-positive population only 48 h posttreatment and onwards. In our experimental model, Ig cross-linking or TPA-sodium butyrate treatment led to an increase in MHC class I expression on the surface of cells that remained in latency compared to that on control untreated cells (Fig. 1B,  upper panels) . This observation contrasts with the findings of Ressing et al., who observed no difference in MHC class I expression between anti-Ig-treated and untreated cells latently infected with the virus (29) . Therefore, in all experiments, we compared GFP ϩ cells replicating the virus with the GFP Ϫ population within the same cultures exposed to lytic cycleinducing stimuli.
To exclude the possibility that the observed effect of virus replication on MHC class I expression was caused by the expression of GFP or other unknown effects mediated by the recombinant virus, wild-type Akata cells were induced to replicate EBV and then costained with the BZLF1-specific antibody and one of the antibodies specific to MHC class I, MHC class II, CD19, or CD86 (Fig. 1C) . As previously reported, surface expression of CD19 and CD86 remained unchanged, whereas levels of MHC class I and II were decreased in cells replicating the virus. All classical MHC class I alleles were downregulated by approximately 60% on average in lytically infected Akata Bx1g cells as revealed by staining with antibodies that recognize pan-HLA-A, pan-HLA-B, or pan-HLA-C (Fig. 1D) .
To get an insight into the role of different EBV proteins in (Fig. 2) . Early gene expression, assessed by staining for the EA-R protein, was undetectable at 6 h but picked up at 12 h, when virtually all cells expressing immediate-early genes also expressed early genes ( Fig. 2A) . At this time point, a small proportion of cells already expressed late genes, as assessed by staining for the envelope glycoprotein gp350/220, but late gene expression by the majority of GFP ϩ cells was seen only at 24 h. The percentage of cells that express lytic cycle genes peaked at 24 h, followed by a decrease at 48 h, which could be due to cell death as a result of lytic replication. Surface MHC class I was slightly upregulated at 6 h postinduction in cells that expressed BZLF1 in comparison to cells that were subjected to anti-Ig treatment but remained in latency. This upregulation was quickly reverted, and by 12 h, MHC class I was reduced by 20%; the extent of downregulation continued to increase, reaching its peak at 48 h. The degree of downregulation varied between individual experiments but averaged 60% by 48 h.
The fact that the surface levels of MHC class I were already decreased by 12 h postinduction, as well as the fact that assembled molecules should have an average half-life of 6 to 8 h, suggested that MHC class I downregulation is induced by an immediate-early or early EBV proteins. In agreement with this assumption and previously published data (16), acyclovir greatly decreased late gene expression in induced Akata cells and reduced percentages of cells expressing BZLF1 but did not significantly affect the levels of BZLF1 expression and MHC class I downregulation in BZLF1-positive cells (Fig. 2B) . The total pool of MHC class I heavy chains and ␤ 2 m is downregulated, whereas free heavy chains accumulate in cells replicating EBV. To understand the fate of MHC class I in cells replicating EBV, we first asked whether the surface downregulation of assembled molecules reflected the overall decrease of heavy chain expression in these cells. Akata Bx1g cells were sorted into GFP Ϫ (latent) and GFP ϩ (lytic) populations at 48 h after induction. Western blot analysis of total cell lysates showed that lytic replication reduces the expression of MHC class I heavy chains as detected by two different heavy chain-specific antibodies (Fig. 3A) . Levels of ␤ 2 m were also strongly reduced. In accordance with downregulation of assembled MHC class I at the cell surface (Fig. 1) , cells subjected to surface IgG cross-linking but remaining in latency (GFP Ϫ ) expressed slightly increased amounts of heavy chains in total cell lysates compared to noninduced controls (Fig. 4A) . Cells in the lytic cycle had reduced levels of total heavy chains in Next, we studied the expression of assembled MHC class I, free heavy chains, and ␤ 2 m both at the cell surface and in permeabilized cells, the latter reflecting the total pool of the analyzed molecules. The density plots in Fig. 3B show a typical surface staining for these molecules at 48 h postinduction. Both assembled MHC class I and ␤ 2 m were decreased in permeabilized cells and on the surface of GFP ϩ cells compared to GFP Ϫ cells at 24 h postinduction, and this downregulation became more pronounced at 48 h (Fig. 3B) . In contrast, the levels of free heavy chain, detected by the MAb HC10, were unchanged at 24 h and tended to increase at 48 h in lytic cells compared to those in cells in latency. Also, downregulation of ␤ 2 m at the cell surface was statistically more significant (P value in nonpaired t test, 0.01) than that of assembled MHC class I after 48 h of lytic cycle induction. A stronger downregulation of ␤ 2 m was also revealed upon staining of permeabilized cells after 24 h of induction (P value, 0.002). Taken together, these results reveal that during EBV replication, expression levels of both heavy chains and ␤ 2 m are downregulated, and ␤ 2 m seems to be reduced to a greater extent. At the same time, both the total pool and surface fraction of free heavy chains are increased, suggesting that free heavy chains selectively accumulate at the surface of cells supporting the lytic cycle.
Proteins that aid the generation of folded and peptideloaded MHC class I are modulated during EBV lytic replication. To investigate whether other mechanisms, in addition to decreased expression of heavy chains and ␤ 2 m, contribute to MHC class I downregulation in lytically infected cells, expression of several components of the MHC class I processing pathway in GFP ϩ and GFP Ϫ Akata Bx1g cells was analyzed by immunoblotting. GFP Ϫ cells were always negative for BZLF1 expression regardless of the time period between induction of the lytic cycle and cell sorting (24 or 48 h). No significant changes could be observed in the expression of LMP2, LMP7, and MECL-1 subunits of the immunoproteasome (Fig. 4A) , nor was there a change in the expression of the nonproteolytic constitutive ␣3 proteasomal subunit. TPPII, another cytosolic peptidase implicated in the generation of MHC class I peptide epitopes, was slightly downregulated.
To compare the expression levels of peptide transporters and ER chaperones that play a role in the assembly and peptide loading of MHC class I, both immunoblotting and flow cytometry analysis of protein expression at the cell surface and in permeabilized cells were used as described for Fig. 3 and in Materials and Methods. Significant accumulation of calnexin was observed mostly in the intracellular compartments of cells in the lytic cycle after 24 h of induction. In contrast, calreticulin accumulated on the surface, while its overall expression was reduced by up to 50% (Fig. 4) . Expression of the chaperone ERp57 showed a general reduction. Tapasin, TAP1, and TAP2 could not be detected at the cell surface by flow cytometry, and their overall levels were not modulated significantly, as detected by immunoblotting, with the exception of TAP2, whose expression was decreased by approximately 30% (Fig. 4) .
MHC class I synthesis is reduced during lytic replication. Herpesviruses target MHC class I molecules for degradation through a number of mechanisms (31) . Therefore, we investigated whether the decrease of MHC class I heavy chain expression in the course of EBV replication is due to inhibition of heavy chain synthesis or targeted protein degradation. Induced and sorted Akata Bx1g cells were labeled with [ 35 S]methionine and [
35 S]cysteine, and their lysates were immunoprecipitated with W6/32 or r␣⌯C antibodies specific to assembled MHC class I or free heavy chains, respectively. After 2 h of labeling, most labeled heavy chains were associated with ␤ 2 m and recovered with W6/32 antibody from control cells (Fig.  5A) . Comparison of GFP Ϫ and GFP ϩ cells revealed a drastic reduction in 35 S-labeled W6/32-and r␣HC-reactive molecules in cells replicating the virus. The amount of de novo-synthesized MHC class I molecules was strongly reduced, by approximately 85% in GFP ϩ cells. Trichloroacetic acid precipitation of [
35 S]methionine-labeled cellular proteins revealed that cells in the lytic cycle incorporated the amino acid at 25% of the level of GFP Ϫ cells in latency (data not shown). This is consistent with overall inhibition of protein synthesis in cells replicating the virus. However, heavy chain downregulation observed by immunoblotting of total lysates of the same cells was relatively moderate, reaching only about 40% reduction in band intensity (Fig. 5B) .
These results could reflect two non-mutually exclusive scenarios, that heavy chains are synthesized at a low rate or newly made molecules are rapidly degraded. To address this question, we performed pulse-chase experiments on sorted cell populations, in which cells were metabolically labeled for 2 min and chased immediately at time zero or 5 or 30 min postlabeling. The cell lysates were sequentially immunoprecipitated with W6/32 and r␣HC antibodies (Fig. 5C ). In cells infected with EBV latently, r␣HC-reactive molecules were visible at time zero and their intensity decreased at the subsequent time points, whereas the amount of assembled, W6/32-reactive MHC class I molecules increased over time. However, both W6/32-and r␣HC-reactive molecules were practically undetectable in cells replicating the virus, supporting the notion that the rate of MHC class I synthesis is low during the EBV lytic cycle. This experiment still did not rule out completely the possibility that heavy chains are synthesized but degraded immediately. Therefore, we pretreated cells with a combination of lactacystin, a specific inhibitor of the proteasome, and chloroquine, an inhibitor of lysosomal degradation, and then performed metabolic labeling and sequential immunoprecipitation as described above (Fig. 5D) . Immunoprecipitation of lysates of GFP Ϫ cells with the W6/32 and r␣HC antibodies showed an accumulation of relevant protein moieties in cells pretreated with the inhibitors. In contrast, neither W6/32-nor r␣HC-reactive species were revealed in cells replicating EBV even upon inhibition of protein degradation. Immunoprecipitation of ␤ 2 m also performed in this series of experiments demonstrated that its synthesis was inhibited in GFP ϩ cells to an extent comparable to that observed for MHC class I heavy chains (data not shown).
To investigate whether decreased transcription/increased turnover of mRNA contributes to the decrease of MHC class I heavy chain synthesis, the abundance of mRNA message for the classical MHC class I molecules and ␤ 2 m was determined using real-time RT-PCR analysis. Since C T values for mRNA of housekeeping genes (G6PD [glucose-6-phosphate dehydrogenase] and Abl protein kinase genes) were increased in GFP ϩ cells (data not shown), normalization to housekeeping gene FIG. 5 . Reduced synthesis of MHC class I is associated with inhibition of transcription during lytic replication. Akata Bx1g cells were induced with anti-IgG for either 48 h (A and B) or 24 h (C, D, E, F, and G) and then sorted into GFP Ϫ and GFP ϩ populations. Both populations were incubated for 1 h at 37°C in methionine-and cysteine-free DMEM prior to metabolic labeling. The bands shown in all experiments correspond to the heavy chain of MHC class I (Ϸ45 kDa). A. Synthesis of MHC class I heavy chains is inhibited during EBV replication. Cells were metabolically labeled for 2 h as described in Materials and Methods and immunoprecipitated with W6/32 or r␣HC antibody. Samples were separated by SDS-PAGE, and autoradiography of dried gels was performed using a PhosphorImager. B. The levels of newly synthesized MHC class I heavy chains are reduced during lytic replication. Equal numbers of GFP Ϫ and GFP ϩ cells were either lysed directly in SDS-containing lysis buffer or labeled with [
35 S]methionine-[ 35 S]cysteine mix for 2 h and immunoprecipitated with W6/32 as described above. Total cell lysates (TCL) were separated by SDS-PAGE, transferred onto nitrocellulose filters, and probed for the heavy chain and actin specific antibody as a loading control. C. Rapid degradation does not appear to account for the decreased levels of newly synthesized heavy chains. Cells were labeled with [
35 S]methionine- [ 35 S]cysteine mix for 2 min and incorporation of radioactivity was terminated by the addition of 1 mM of nonradioactive L-methionine and L-cysteine. Samples were pelleted and frozen either immediately (time zero) or after 5 and 30 min of chase, followed by sequential immunoprecipitation with W6/32 and r␣HC antibody. Electrophoresis and autoradiography were performed as described above. D. Inhibitors of proteasomal or lysosomal degradation do not recover expression of newly synthesized heavy chains. Cells were incubated in methionine-and cysteine-free DMEM for 1 h in the presence of both proteasomal inhibitor lactacysin (10 M) and lysosomal inhibitor chloroquine (4 M), labeled for 20 min with 400 Ci [
35 S]methionine-[ 35 S]cysteine followed by sequential immunoprecipitation with W6/32 and r␣HC, electrophoresis, and autoradiography. E. MHC class I heavy chain and ␤ 2 m mRNA are reduced in cells in lytic replication. After sorting, GFP Ϫ and GFP ϩ cells were carefully counted and pellets of equal numbers of cells were used for reverse transcription and RT-PCR analysis of MHC class I and ␤2m mRNA. Values of relative expression of these mRNAs in GFP ϩ relative to GFP Ϫ cells are shown. Means and standard deviations of three independent experiments. F. Inhibition of protein synthesis mimics the effect of lytic replication on downregulation of assembled surface MHC class I and class II molecules. Akata Bx1g cells were either cultured in control medium, treated with 50 g/ml cycloheximide or induced into lytic cycle for 24 h and then stained for surface MHC class I and II. The expression levels of MHC class I and II on both GFP ϩ and cycloheximide-treated cells are shown as percentages relative to those in GFP Ϫ or untreated cells, respectively. G. Assembled MHC class I molecules synthesized in lytically infected cells are delayed in their maturation. Cells metabolically labeled for 30 min were incubated in prewarmed DMEM containing excesses of unlabeled L-methionine and L-cysteine and 10% fetal calf serum. Samples were collected immediately after the pulse (time zero) and at 1 h or 2 h of incubation. After immunoprecipitation with W6/32, assembled MHC class I was eluted from the Sepharose beads, digested by endoH (2 mM) and separated by SDS-PAGE together with nondigested controls. The line graph shows ratios between the intensities of endoH-resistant and -sensitive bands in GFP ϩ and GFP Ϫ cells.
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on August 29, 2017 by guest http://jvi.asm.org/ expression levels could not be used to assess the abundance of MHC class I and ␤ 2 m mRNAs. Instead, normalization was achieved by extracting mRNA from equal numbers of sorted GFP Ϫ and GFP ϩ cells. As shown in Fig. 5E , the mRNA message for MHC class I was reduced by an average of 70%, whereas the ␤ 2 m message was reduced by approximately 60%.
To test directly whether global inhibition of protein synthesis can cause MHC class I downregulation in Akata Bx1g cells within the timeframe of experiments performed in this study, cells were either treated to induce the lytic cycle or incubated with 50 g/ml of cycloheximide for 24 h (Fig. 5F ). GFP ϩ cells were compared to anti-Ig-treated GFP Ϫ cells, while untreated cells served as a control for cycloheximide-treated cells. EBV replication and inhibition of protein synthesis by cycloheximide resulted in comparable reduction of MHC class I and class II expression.
Inhibition of TAP-mediated peptide translocation into the ER during EBV replication has been previously suggested (29) . Our results revealed a slight inhibition of TAP2 expression as well as downregulation of TPPII and ERp57 in cells replicating the virus. All these changes could decrease the efficiency of peptide supply and loading in lytically infected cells, thereby affecting the kinetics of MHC class I progression through the ER and Golgi apparatus. To assess the efficiency of this process, Akata Bx1g cells were induced, sorted, labeled for 30 min with [
35 S]methionine-[ 35 S]cysteine, and chased at the indicated time points after the pulse. After immunoprecipitation with W6/32 antibodies, samples were divided and either mock treated or treated with endoH, an enzyme which removes N-linked oligosaccharides attached to proteins in the ER but does not trim modified versions of these sugars acquired in the Golgi compartment. It has been previously demonstrated that the kinetics of MHC class I maturation is relatively slow in Akata cells due to their intrinsically low TAP activity (10, 17) . Accordingly, a proportion of MHC class I molecules remained endoH sensitive even after 2 h of chase in the control GFP-negative cells (Fig. 5G ). In agreement with the previous experiments, bands of very low intensity were detected in MHC class I immunoprecipitates from the lysates of GFP ϩ Akata Bx1g cells. Although it was clear that MHC class I molecules in cells replicating EBV progress to the Golgi, densitometry of endoH-sensitive and endoH-resistant bands indicated that there was a delay in MHC class I maturation during the EBV lytic cycle. However, this delay was revealed only upon a comparison of samples obtained at 2 h of chase and its significance for the phenomenon of MHC class I downregulation remains unclear.
DISCUSSION
Study of EBV replication was hampered for a long time by the lack of a permissive in vitro system. We hereby present a model for studying EBV replication that is based on a recombinant virus which drives GFP expression in infected cells during the lytic cycle, enabling us to distinguish and sort cells supporting virus replication from cells that remain in latency. We found that, at least in Akata Bx1g cells, GFP expression, driven by the immediate-early CMV promoter from a cassette inserted into the thymidine kinase gene of the EBV genome, largely coincides with expression of early and late lytic cycle genes. The fact that high levels of GFP expression in Akata Bx1g cells are observed only upon induction of the lytic cycle is most likely explained by upregulation of the CMV promoter activity or regulatory effects of the two thymidine kinase promoters which lie upstream of the CMV promoter in the recombinant EBV strain and become activated in cells supporting EBV replication. An increase in EBV copy numbers during the lytic cycle is unlikely to contribute to this phenomenon, because inhibition of EBV DNA synthesis by acyclovir does not significantly affect GFP expression in anti-Ig-stimulated Akata cells. In the present study, we utilized this model to analyze the influence of the EBV lytic cycle on the MHC class I processing and presentation pathway. We observed that EBV replication results in MHC class I downregulation at the cell surface of Burkitt's lymphoma Akata cells, as well as the epithelial cell lines AGS and HCT116, infected with the recombinant EBV strain (Fig. 1) . Kinetic analysis of viral gene expression in Akata cells indicated that the MHC class I downregulation precedes the expression of late genes of the EBV lytic cycle. Accordingly, treatment with acyclovir, which blocks late EBV gene expression and virus DNA replication, did not prevent MHC class I downregulation in cells expressing GFP and BZLF1 following anti-Ig cross-linking (Fig. 2) . It is not surprising that the recombinant virus retains sensitivity to acyclovir even though its thymidine kinase gene is disrupted, because EBV thymidine kinase does not phosphorylate acyclovir and the effect of this drug is determined by the exquisite sensitivity of the viral DNA polymerase to phosphorylated acyclovir presumably generated by cellular or other viral kinases (12, 26) .
MHC class I downregulation in the course of EBV replication observed in our model recapitulates recent findings by Ressing et al., who characterized this phenomenon by using EBV-positive Akata cells transfected with a reporter plasmid in which expression of the extracellular and transmembrane domains of the rat CD2 molecule, with GFP replacing the functional cytosolic domain, is driven by the early BZLF1-responsive promoter (29) . Here we extend this finding towards more extensive characterization of the MHC class I-processing pathway during the course of EBV replication. We demonstrate that the expression levels of MHC class I molecules encoded by each of the three loci, A, B, or C, are decreased to similar extents on the surface of cells in the lytic cycle (Fig.  1D ). This correlates with significantly decreased levels of MHC class I heavy chains and ␤ 2 m in total cell lysates ( Fig. 3 and 4) . Interestingly, Ressing et al. have not observed any modulation of heavy chain levels in their model of EBV replication (29) . This discrepancy can be partly explained by the fact that in the previous study, cells replicating the virus were compared to untreated cells in culture, while we observed a significant MHC class I upregulation on the surface of cells which were subjected to lytic cycle-inducing stimuli, e.g., anti-Ig antibody, but remained in latency (Fig. 1B) . Therefore, in our analysis, we always compared cells in the lytic cycle to similarly treated cells in latency obtained by sorting the same cell culture into GFP ϩ and GFP Ϫ populations. In contrast to the changes observed in the total pool of heavy chains, free heavy chains accumulated in cells supporting EBV replication (Fig. 3B) . In activated human T cells, MHC class I molecules coexist in two conformation states, folded and misfolded, and can be identified by the monoclonal antibodies W6/32 and HC10, respectively. In these cells, the pool of misfolded heavy chains is found in association with calreticulin and ERp57 (3, 30) . Our results point to a possible role of both calreticulin and calnexin in stabilizing different pools of free heavy chains. Although calreticulin and, to a lesser extent, calnexin accumulate on the surface of cells supporting the virus lytic cycle, the levels of calreticulin in total cell lysates are reduced, whereas calnexin is increased (Fig. 4) . This suggests that a proportion of free heavy chains could be stabilized by calnexin intracellularly, whereas calreticulin aids their stabilization at the surface. It is also possible that some free heavy chains associated with chaperones and especially with calreticulin acquire a folded conformation, which is seen by the W6/32 antibody. That could explain why ␤ 2 m seems to be downregulated to a greater extent than assembled MHC class I molecules in cells replicating the virus (Fig. 3B) .
Although it has been suggested that free heavy chains and MHC class I molecules devoid of peptides can interact with NK cell receptors and modulate the functional outcome of target cell recognition by NK cells (2, 7, 22) , it remains to be established whether the accumulation of free MHC class I heavy chains at the cell surface serves any immunological function in cells replicating EBV.
Calreticulin is found in the ER membrane, the nucleus, and on the cell surface of most mammalian cells. Cellular stress, including apoptosis, induces expression of calreticulin and leads to an increase of its cell surface expression and redistribution, whereby calreticulin becomes associated with phosphatidylserine (11) . At least in part, the surface accumulation of calreticulin could be a reflection of apoptotic changes associated with EBV replication but could also have different functional implications. Calreticulin has been shown to interact with perforin and inhibit perforin-mediated killing. This protection seems to occur independently of direct interaction with perforin, and it has been proposed that calreticulin stabilizes the membrane and prevents pore formation induced by perforin (9) . Although MHC class I downregulation may lead to increased sensitivity of cells to NK lysis (20) , functional consequences of EBV replication in terms of its effect on recognition by CTLs or NK cells remain to be characterized, and calreticulin could affect perforin-mediated lysis of EBV-infected cells during the lytic cycle.
Pulse-chase analysis of MHC class I molecules in cells replicating EBV showed a strong reduction in the levels of newly made heavy chains and ␤ 2 m (Fig. 5) . Targeting proteins for degradation is a common strategy utilized by herpesviruses to ensure their persistence and/or escape from immune surveillance (see reference 27 for a review). In particular, cytomegalovirus encodes at least two proteins, US2 and US11, which target MHC class I heavy chains for retrograde transport from the ER to cytosol (21, 35) . A decrease in the amount of newly made heavy chains was clearly detected after brief metabolic labeling and could not be rescued by a combination of proteasomal and lysosomal inhibitors, strongly suggesting that targeting of heavy chains for protein degradation does not play a role in the observed MHC class I downregulation ( Fig. 5C and D) . Ressing et al. have shown that the functional activity of the TAP heterodimer is inhibited during EBV replication, although the expression of TAP1 and TAP2 appeared to be unaffected (29) . In our system, expression of TAP2, but not TAP1, was decreased by about 30% in cells supporting virus replication (Fig. 4) . We also observed downregulation of ERp57, another functionally important member of the peptide loading complex, and TPPII, an endopeptidase implicated in the generation of peptide ligands presented by MHC class I molecules. These changes could, indeed, result in a lower efficiency of MHC class I assembly, which is usually reflected in delayed class I maturation, as assessed by changes in the endoH sensitivity of sugars attached to these molecules and modified during their progression from the ER to the Golgi compartment. We detected a delay in MHC class I maturation during the EBV lytic cycle in Akata cells; however, this delay was revealed only upon comparison of samples obtained at 2 h of chase (Fig. 5G) , and its significance for the phenomenon of MHC class I downregulation remains unclear. It is conceivable that strong inhibition of MHC class I heavy chain synthesis observed during EBV replication minimizes competition of newly produced heavy chains for available peptide ligands, even if the latter are supplied at a decreased rate due to inhibition of the TAP heterodimer. Whether inhibition of TAP function plays a more significant role at a particular stage of the virus lytic cycle remains to be determined.
Nonspecific inhibition of protein synthesis by cycloheximide causes downregulation of MHC class I comparable to that observed in Akata cells during the EBV lytic cycle (Fig. 5F ). The notion that the inhibition of MHC class I heavy chain and ␤ 2 m synthesis plays the primary role in MHC class I downregulation in the course of EBV replication is consistent with a recent demonstration of skewing of EBV lytic cycle-specific CTL responses towards the immediate-early and early proteins (28) . In this scenario, the immediate-early and early proteins could be still processed and presented before the virus-induced inhibition of protein synthesis comes into force and the existing pool of nonassembled heavy chains and ␤ 2 m gets depleted. A detailed discussion of mechanisms which could account for the inhibition of MHC class I synthesis by the immediate-early or early proteins of the EBV lytic cycle is outside the scope of this article. It has been proposed that the activity of LMP1, which induces the IRF7 transcription factor and upregulates MHC class I expression (37, 38) , can be counteracted by BZLF1 through its interference with IRF7 (14) . MHC class I upregulation induced by B-cell-receptor triggering involves NF-B and can also be counteracted by BZLF1 through its interference with the NF-B p65 subunit (13, 25) . However, these mechanisms do not seem to be sufficient, because the level of class I synthesis in cells replicating EBV is much lower than that in noninduced control Akata cells, which have not received an activating signal and do not express LMP1. Other mechanisms may be at play in inhibiting basic transcription of MHC class I molecules and potentially include BZLF1-dependent inhibition of transcription factors such as CREB and TBP (1, 23) , as well as inhibition of nuclear export of spliced cellular mRNAs by BMLF1 (4, 33) . Regardless of the specific molecular event(s) involved in this phenomenon, our data strongly suggest that virus-mediated inhibition of protein synthesis through reduction of mRNA expression is the major mechanism of MHC class I downregulation during the EBV lytic cycle. 
